BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 11681866)

  • 21. The natural history of dilated cardiomyopathy: how has it changed?
    Merlo M; Gentile P; Naso P; Sinagra G
    J Cardiovasc Med (Hagerstown); 2017 Jan; 18 Suppl 1():e161-e165. PubMed ID: 27828827
    [No Abstract]   [Full Text] [Related]  

  • 22. Direct effects of 3 combinations of enalapril, metoprolol, and spironolactone on cardiac remodeling in dilated cardiomyopathic hamsters.
    Laviolle B; Pape D; Turlin B; Bellissant E
    J Card Fail; 2006 Dec; 12(9):752-8. PubMed ID: 17174238
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Possibilities of testosterone in complex therapy of patients with dilated cardiomyopathy].
    Kurbanov RD; Abdullaev TA; Mardanov BU
    Kardiologiia; 2009; 49(12):50. PubMed ID: 20038282
    [No Abstract]   [Full Text] [Related]  

  • 24. Efficacy of benazepril hydrochloride to delay the progression of occult dilated cardiomyopathy in Doberman Pinschers.
    O'Grady MR; O'Sullivan ML; Minors SL; Horne R
    J Vet Intern Med; 2009; 23(5):977-83. PubMed ID: 19572914
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Geriatric heart diseases in dogs.
    Hamlin RL
    Vet Clin North Am Small Anim Pract; 2005 May; 35(3):597-615. PubMed ID: 15833561
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pathogenesis and treatment of cardiomyopathy.
    Fonarow GC
    Adv Intern Med; 2001; 47():1-45. PubMed ID: 11795071
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cardiomyopathy. Diagnosis and management of dilated cardiomyopathy.
    Elliott P
    Heart; 2000 Jul; 84(1):106-12. PubMed ID: 10862601
    [No Abstract]   [Full Text] [Related]  

  • 28. Treatment of severe chronic digoxin toxicosis in a dog with cardiac disease, using ovine digoxin-specific immunoglobulin G Fab fragments.
    Ward DM; Forrester SD; DeFrancesco TC; Troy GC
    J Am Vet Med Assoc; 1999 Dec; 215(12):1808-12, 1806. PubMed ID: 10613212
    [TBL] [Abstract][Full Text] [Related]  

  • 29. L-carnitine supplementation in the therapy of canine dilated cardiomyopathy.
    Keene BW
    Vet Clin North Am Small Anim Pract; 1991 Sep; 21(5):1005-9. PubMed ID: 1949496
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Mitochondrial cardiomyopathy].
    Tanaka M
    Nihon Rinsho; 2002 Apr; 60 Suppl 4():306-11. PubMed ID: 12013873
    [No Abstract]   [Full Text] [Related]  

  • 31. [Case presentation in small animal medicine. What is your diagnosis?].
    Gut M; Glaus TM; Suter PF
    Schweiz Arch Tierheilkd; 1998; 140(8):337-40. PubMed ID: 9719733
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Taurine and carnitine in canine cardiomyopathy.
    Sanderson SL
    Vet Clin North Am Small Anim Pract; 2006 Nov; 36(6):1325-43, vii-viii. PubMed ID: 17085238
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Normalization of ejection fraction and resolution of symptoms in chronic severe heart failure is possible with modern medical therapy: clinical observations in 11 patients.
    Harinstein ME; Berliner JI; Shah SJ; Taegtmeyer H; Gheorghiade M
    Am J Ther; 2008; 15(3):206-13. PubMed ID: 18496257
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cardiac monitoring and treatment for children and adolescents with neuromuscular disorders.
    Bourke JP
    Dev Med Child Neurol; 2006 Mar; 48(3):164. PubMed ID: 16483389
    [No Abstract]   [Full Text] [Related]  

  • 35. Expression and biochemical characteristics of two different aldosterone receptors in both healthy and dilated cardiomyopathy dog heart tissue.
    Reynoso Palomar AR; Rodriguez Bravo M; Villa Mancera AE; Mucha CJ
    Vet Res Commun; 2017 Mar; 41(1):9-14. PubMed ID: 27891565
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Timing of prophylactic implantable cardioverter-defibrillator implantation in patients with cardiomyopathy.
    Littmann L; Narveson SY; Fesel NM; Marconi SL
    Am J Cardiol; 2012 Jul; 110(1):161-2. PubMed ID: 22704297
    [No Abstract]   [Full Text] [Related]  

  • 37. Preclinical dilated cardiomyopathy in the dobermann.
    Summerfield N; Dukes-McEwan J; Swift S; Patteson M; Wotton P; Martin M; Johnson M; Boswood A; Fuentes VL; French A; Culshaw G; Little C; Smith P; Smith S; Willis R
    Vet Rec; 2006 May; 158(21):742-3. PubMed ID: 16731709
    [No Abstract]   [Full Text] [Related]  

  • 38. The vasovagal tonus index as a prognostic indicator in dogs with dilated cardiomyopathy.
    Pereira YM; Woolley R; Culshaw G; French A; Martin M
    J Small Anim Pract; 2008 Nov; 49(11):587-92. PubMed ID: 19006490
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Relationship between circulating and dietary taurine concentrations in dogs with dilated cardiomyopathy.
    Freeman LM; Rush JE; Brown DJ; Roudebush P
    Vet Ther; 2001; 2(4):370-8. PubMed ID: 19746660
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Canine heart disease: progress and promise.
    Oyama MA
    J Small Anim Pract; 2008 Nov; 49(11):549-50. PubMed ID: 19006487
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.